Sangamo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SGMO and other ETFs, options, and stocks.About SGMO
Sangamo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the research and development of zinc finger proteins. It focuses on three therapeutic areas: inherited metabolic diseases, central nervous system, and diseases and immunology, which consist of inflammatory and autoimmune diseases.
CEOAlexander D. Macrae
CEOAlexander D. Macrae
Employees183
Employees183
HeadquartersRichmond, California
HeadquartersRichmond, California
Founded1995
Founded1995
Employees183
Employees183
SGMO Key Statistics
Market cap147.07M
Market cap147.07M
Price-Earnings ratio-0.93
Price-Earnings ratio-0.93
Dividend yield—
Dividend yield—
Average volume5.16M
Average volume5.16M
High today$0.4443
High today$0.4443
Low today$0.42
Low today$0.42
Open price$0.4202
Open price$0.4202
Volume3.71M
Volume3.71M
52 Week high$2.84
52 Week high$2.84
52 Week low$0.411
52 Week low$0.411
Stock Snapshot
Sangamo Therapeutics(SGMO) stock is priced at $0.44, giving the company a market capitalization of 147.07M. It carries a P/E multiple of -0.93.
On 2025-11-18, Sangamo Therapeutics(SGMO) stock moved within a range of $0.42 to $0.44. With shares now at $0.44, the stock is trading +3.8% above its intraday low and -1.9% below the session's peak.
Trading activity shows a volume of 3.71M, compared to an average daily volume of 5.16M.
The stock's 52-week range extends from a low of $0.41 to a high of $2.84.
The stock's 52-week range extends from a low of $0.41 to a high of $2.84.
People also own
Based on the portfolios of people who own SGMO. This list is generated using Robinhood data, and it’s not a recommendation.